12 months ago a US Federal court judge said Teva ,Mylan, Heritage Pharma couldn't dodge anti trust claims of them conpiring to increase the price of a generic blood pressure medication.
A former Teva employee has also launched a class action saying the company concealed price fixing.
September 2016 Teva launch a generic daptomycin ( no competition from Mylan ).
Is this not something the Arbitrator would be mulling over?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.002(30.0%) |
Mkt cap ! $19.04M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $85.50K | 14.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 7597071 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 6487255 | 16 |
View Market Depth
| Last trade - 12.05pm 13/08/2025 (20 minute delay) ? |
| AVE (ASX) Chart |